Cargando…

Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines

BACKGROUND: The neuroinflammatory responses in the spinal cord following bone cancer development have been shown to play an important role in cancer-induced bone pain (CIBP). Lipoxins (LXs), endogenous lipoxygenase-derived eicosanoids, represent a unique class of lipid mediators that possess a wide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Shan, Mao-Ying, Qi-Liang, Wang, Jun, Wang, Zhi-Fu, Mi, Wen-Li, Wang, Xiao-Wei, Jiang, Jian-Wei, Huang, Ya-Lin, Wu, Gen-Cheng, Wang, Yan-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558391/ https://www.ncbi.nlm.nih.gov/pubmed/23268791 http://dx.doi.org/10.1186/1742-2094-9-278

Ejemplares similares

Lipoxin and Aspirin-Triggered Lipoxins
por: Romano, Mario
Publicado: (2010)

Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing
por: Svensson, Camilla I., et al.
Publicado: (2007)

Lipid-Derived Mediators in Endogenous Anti-Inflammation and Resolution: Lipoxins and Aspirin-Triggered 15-epi-Lipoxins
por: Serhan, Charles N., et al.
Publicado: (2002)

Activation of Lipoxin a(4) Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation
por: Chiang, Nan, et al.
Publicado: (2000)

Lipoxin Receptors
por: Romano, Mario, et al.
Publicado: (2007)

Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6
por: Machado, Fabiana S., et al.
Publicado: (2008)

Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6
por: Machado, Fabiana S., et al.
Publicado: (2009)

Lipoxins in the Nervous System: Brighter Prospects for Neuroprotection
por: Zhang, Jiayu, et al.
Publicado: (2022)

Lipoxins: nature’s way to resolve inflammation
por: Chandrasekharan, Jayashree A, et al.
Publicado: (2015)

Dysregulation of Neuroprotective Lipoxin Pathway in Astrocytes in Response to Cytokines and Ocular Hypertension
por: Karnam, Shruthi, et al.
Publicado: (2023)

Lipoxins as biomarkers of lupus and other inflammatory conditions
por: Das, Undurti N
Publicado: (2011)

Lipoxins: A Novel Regulator in Embryo Implantation
por: Xiong, Jing, et al.
Publicado: (2011)

Release of cyclooxygenase-2 and lipoxin A(4) from blood leukocytes in aspirin-exacerbated respiratory disease
por: Rozsasi, Ajnacska, et al.
Publicado: (2016)

The Lipoxin A4 Receptor Agonist BML-111 Alleviates Inflammatory Injury and Oxidative Stress in Spinal Cord Injury
por: Liu, Jian, et al.
Publicado: (2020)

Synthesis of aromatic lactone analogues of Lipoxin A4
por: Ismael, Aya, et al.
Publicado: (2022)

Dysregulation of prostaglandins, leukotrienes and lipoxin A(4) in bronchiectasis
por: Bedi, Pallavi, et al.
Publicado: (2022)

Promising Anti-Inflammatory Tools: Biomedical Efficacy of Lipoxins and Their Synthetic Pathways
por: Chi, Junxi, et al.
Publicado: (2023)

A Novel Thermoresponsive Gel as a Potential Delivery System for Lipoxin
por: Wang, B., et al.
Publicado: (2018)

The effect of low-dose aspirin on aspirin triggered lipoxin, interleukin 1 beta, and prostaglandin E2 levels in periapical fluid: a double-blind randomized clinical trial
por: Khoshbin, Elham, et al.
Publicado: (2023)

Lipoxin A(4) and 15-Epi-Lipoxin A(4) Protect against Experimental Cerebral Malaria by Inhibiting IL-12/IFN-γ in the Brain
por: Shryock, Nathaniel, et al.
Publicado: (2013)

Age-linked suppression of lipoxin A4 associates with cognitive deficits in mice and humans
por: Pamplona, Fabricio A., et al.
Publicado: (2022)

Aspirin-triggered 15-epi-lipoxin A(4) predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test
por: Kirkby, Nicholas S., et al.
Publicado: (2013)

Aspirin-triggered lipoxin A(4 )attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells
por: Wang, Yan-Ping, et al.
Publicado: (2011)

15-epi-lipoxin A(4)–mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute Inflammation
por: Paul-Clark, Mark J., et al.
Publicado: (2004)

The role of Lipoxin A4 in Cystic Fibrosis Lung Disease
por: Urbach, Valérie, et al.
Publicado: (2013)

Effect of Lipoxin A(4) on Lipopolysaccharide-Induced Endothelial Hyperpermeability
por: Pang, Huayan, et al.
Publicado: (2011)

Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease
por: Pirault, John, et al.
Publicado: (2018)

Lipoxins and Resolvins in Patients With Pancreatic Cancer: A Preliminary Report
por: Blogowski, Wojciech, et al.
Publicado: (2022)

Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases
por: Jaén, Rafael I., et al.
Publicado: (2021)

Role of the lipoxin A4 receptor in the development of neutrophil extracellular traps in Leishmania infantum infection
por: Wei, Furong, et al.
Publicado: (2019)

Lipoxin A(4) suppresses angiotensin II type 1 receptor autoantibody in preeclampsia via modulating caspase-1
por: Liu, Haojing, et al.
Publicado: (2020)

Lipoxin A4 and its analog suppress inflammation by modulating HMGB1 translocation and expression in psoriasis
por: Liu, Xinxin, et al.
Publicado: (2017)

Simvastatin Upregulates Lipoxin A4 and Accelerates Neuroinflammation Resolution After Intracerebral Hemorrhage
por: Zhang, Jianbo, et al.
Publicado: (2022)

Lipoxin (LX)A(4) and Aspirin-triggered 15-epi-LXA(4) Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis
por: Hachicha, Mohamed, et al.
Publicado: (1999)

Neuroprotective Effects of Lipoxin A4 in Central Nervous System Pathologies
por: Martini, Alessandra Cadete, et al.
Publicado: (2014)

Lipoxins and Annexin-1: Resolution of Inflammation and Regulation of Phagocytosis of Apoptotic Cells
por: Scannell, Michael, et al.
Publicado: (2006)

Could Lipoxins Represent a New Standard in Ischemic Stroke Treatment?
por: Tułowiecka, Nikola, et al.
Publicado: (2021)

The effect of lipoxin A4 on E. coli LPS-induced osteoclastogenesis
por: Ali, Muhanad, et al.
Publicado: (2020)

LipoxinA4 as a Potential Prognostic Marker of COVID-19
por: Jamali, Farzaneh, et al.
Publicado: (2022)

Potential role of lipoxin in the management of COVID-19: a narrative review
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0envte5q72sld1uqv3k72jblg4